Mucositis is a distressing and common consequence in Chemo radiation patients, with varied incidence and severity. In diverse patient populations, certain clinical variables are linked to the occurrence and severity of mucositis. Early prediction techniques based on such clinical characteristics may aid clinicians in implementing a variety of preventative interventions in high-risk patients.
To see how effective two distinct technologies are at predicting different types of mucositis.
Methods- From January 2019 to November 2020, we conducted a prospective observational (non-interventional) study with 438 patients, who were followed up to April 2021 using two published techniques for predicting the severity of mucositis. The population comprises of patients with head and neck squamous cell cancer who have been allocated to receive chemoradiotherapy and who have been divided into three risk groups using the techniques mentioned above: low, intermediate, and high. They were followed up on to see if they developed mucositis and how severe it was.
Identifying high-risk patients prior to the start of chemoradiotherapy for the purpose of predicting mucositis can assist clinicians in taking strict preventive measures to avoid or reduce the severity of the serious adverse effect, thereby improving the quality of life and avoiding treatment interruption.